These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38890190)

  • 41. DJ‑1 is a new prognostic marker and predicts chemotherapy efficacy in colorectal cancer.
    Wang W; Wang H; Xiang L; Ni T; Jin F; Deng J; Zhang Y; Shintaro I; Zhou Y; Liu Y
    Oncol Rep; 2020 Jul; 44(1):77-90. PubMed ID: 32627002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumor activity of dictamnine against colorectal cancer through induction of ferroptosis and inhibition of M2 macrophage polarization via the MAPK signaling.
    Zuo X; Lin H; Song Z; Yu B; Zhao C
    Arch Biochem Biophys; 2024 Aug; 758():110051. PubMed ID: 38851368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancer.
    McCann C; Matveeva A; McAllister K; Van Schaeybroeck S; Sessler T; Fichtner M; Carberry S; Rehm M; Prehn JHM; Longley DB
    FEBS J; 2021 Sep; 288(18):5374-5388. PubMed ID: 33660894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L.
    Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L
    Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LINC00982-encoded protein PRDM16-DT regulates
    Hu HF; Han L; Fu JY; He X; Tan JF; Chen QP; Han JR; He QY
    Theranostics; 2024; 14(8):3317-3338. PubMed ID: 38855188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Baicalein triggers ferroptosis in colorectal cancer cells via blocking the JAK2/STAT3/GPX4 axis.
    Lai JQ; Zhao LL; Hong C; Zou QM; Su JX; Li SJ; Zhou XF; Li ZS; Deng B; Cao J; Qi Q
    Acta Pharmacol Sin; 2024 Aug; 45(8):1715-1726. PubMed ID: 38684798
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116.
    Kukcinaviciute E; Jonusiene V; Sasnauskiene A; Dabkeviciene D; Eidenaite E; Laurinavicius A
    J Cell Biochem; 2018 Jul; 119(7):5913-5920. PubMed ID: 29637602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.
    Narayan S; Ramisetti S; Jaiswal AS; Law BK; Singh-Pillay A; Singh P; Amin S; Sharma AK
    Eur J Med Chem; 2019 Jan; 161():456-467. PubMed ID: 30384048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis.
    Ming T; Lei J; Peng Y; Wang M; Liang Y; Tang S; Tao Q; Wang M; Tang X; He Z; Liu X; Xu H
    Phytother Res; 2024 Aug; 38(8):3954-3972. PubMed ID: 38837315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. miR-203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase.
    Zhou Y; Wan G; Spizzo R; Ivan C; Mathur R; Hu X; Ye X; Lu J; Fan F; Xia L; Calin GA; Ellis LM; Lu X
    Mol Oncol; 2014 Feb; 8(1):83-92. PubMed ID: 24145123
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigallocatechin-3-gallate targets cancer stem-like cells and enhances 5-fluorouracil chemosensitivity in colorectal cancer.
    Toden S; Tran HM; Tovar-Camargo OA; Okugawa Y; Goel A
    Oncotarget; 2016 Mar; 7(13):16158-71. PubMed ID: 26930714
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer.
    Zhao Y; Wang C; Goel A
    Carcinogenesis; 2021 Jun; 42(6):814-825. PubMed ID: 33822896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TMEM120A-mediated regulation of chemotherapy sensitivity in colorectal cancer cells.
    Wang L; Liu X
    Cancer Chemother Pharmacol; 2024 Jan; 93(1):11-22. PubMed ID: 37728615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oligomeric proanthocyanidins (OPCs) from grape seed extract suppress the activity of ABC transporters in overcoming chemoresistance in colorectal cancer cells.
    Ravindranathan P; Pasham D; Goel A
    Carcinogenesis; 2019 May; 40(3):412-421. PubMed ID: 30596962
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circ_0000395 promotes cell growth, metastasis and oxaliplatin resistance by regulating miR-153-5p/MYO6 in colorectal cancer.
    Xiao L; Zhu Y; Xu H; Lin L; Li M; Zhou Y
    Pathol Res Pract; 2024 Aug; 260():155476. PubMed ID: 39038387
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selumetinib overcomes ITGA2-induced 5-fluorouracil resistance in colorectal cancer.
    Qin J; Hu S; Lou J; Xu M; Gao R; Xiao Q; Chen Y; Ding M; Pan Y; Wang S
    Int Immunopharmacol; 2024 Aug; 137():112487. PubMed ID: 38889513
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids.
    Elbadawy M; Hayashi K; Ayame H; Ishihara Y; Abugomaa A; Shibutani M; Hayashi SM; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Shinohara Y; Kaneda M; Yamawaki H; Usui T; Sasaki K
    Biomed Pharmacother; 2021 Oct; 142():112043. PubMed ID: 34411919
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Melatonin-mediated downregulation of thymidylate synthase as a novel mechanism for overcoming 5-fluorouracil associated chemoresistance in colorectal cancer cells.
    Sakatani A; Sonohara F; Goel A
    Carcinogenesis; 2019 May; 40(3):422-431. PubMed ID: 30590435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase
    Luo W; Liu Q; Chen X; Liu H; Quan B; Lu J; Zhang K; Wang X
    Biomed Res Int; 2021; 2021():9986376. PubMed ID: 34212047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.